Dogwood Therapeutics, Inc.
DWTXHealthcare|Biotechnology|US
$1.28
+0.24 (+23.08%)
DCF Value
$0.69
Cash / Share
$144984.79
Clinical Trials (1)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT06848348 Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain | Chemotherapy Induced Neuropathic Pain, Chemotherapy Induced Pain Neuropathy | P2 | Active | 240 | RCT, Double-blind | Halneuron, Placebo, Halneuron (Open Label Extension) |